The educational toolkit raises awareness of GA and its therapeutic targets

CAMBRIDGE, MA — The Angiogenesis Foundation announced it has launched a multimedia educational toolkit designed to raise awareness among ophthalmologists, retina specialists, and optometrists about geographic atrophy (GA), its pathology, progression, mechanisms, emerging targets, and associated clinical trials. The toolkit, which includes 3D medical visualizations of the progression from early disease changes in the retina to GA, will be first available at Euretina 2017.

“Geographic atrophy is a huge contributor to AMD-related blindness worldwide,” said Dr. William Li, President and Medical Director of the Angiogenesis Foundation. “While exciting treatments for GA are now on the horizon, many doctors don’t fully understand the disease. Our goal is to raise awareness of GA on a global level and how emerging treatments are targeting disease progression.”

“Having effective treatments for GA would be game-changing,” said Diana Saville, Chief Innovation Officer of the Angiogenesis Foundation. “Our toolkit is the first in a series of important resources we will launch for physicians to better understand the condition.”

The Foundation’s Geographic Atrophy toolkit is a user-friendly multimedia resource that unpacks the rigorous science in an easy-to-understand guide accompanied by visually-striking medical graphics. To learn more about this important resource, please visit